Terms: = Kidney tumors AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Diagnosis
10 results:
1. The prevalence and associated risk factors of detectable renal morphological abnormalities in acromegaly.
Bostan H; Kizilgul M; Calapkulu M; Kalkisim HK; Topcu FBG; Gul U; Duger H; Hepsen S; Ucan B; Cakal E
Pituitary; 2024 Feb; 27(1):44-51. PubMed ID: 38064149
[TBL] [Abstract] [Full Text] [Related]
2. The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention.
Khan T; Kryza T; Lyons NJ; He Y; Hooper JD
Cancer Res; 2021 May; 81(9):2259-2269. PubMed ID: 33509939
[TBL] [Abstract] [Full Text] [Related]
3. First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET.
Krebs S; Veach DR; Carter LM; Grkovski M; Fornier M; Mauro MJ; Voss MH; Danila DC; Burnazi E; Null M; Staton K; Pressl C; Beattie BJ; Zanzonico P; Weber WA; Lyashchenko SK; Lewis JS; Larson SM; Dunphy MPS
J Nucl Med; 2020 Nov; 61(11):1580-1587. PubMed ID: 32169913
[TBL] [Abstract] [Full Text] [Related]
4. Renal cell carcinoma originating in the free wall of simple renal cyst: Two unusual case reports with literature review.
Lai S; Jiao B; Wang X; Xu X; Zhang M; Diao T; Zhang G
Medicine (Baltimore); 2019 Apr; 98(16):e15249. PubMed ID: 31008960
[TBL] [Abstract] [Full Text] [Related]
5. RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs.
Beuselinck B; Jean-Baptiste J; Couchy G; Job S; De Reynies A; Wolter P; Théodore C; Gravis G; Rousseau B; Albiges L; Joniau S; Verkarre V; Lerut E; Patard JJ; Schöffski P; Méjean A; Elaidi R; Oudard S; Zucman-Rossi J
Br J Cancer; 2015 Nov; 113(9):1313-22. PubMed ID: 26528707
[TBL] [Abstract] [Full Text] [Related]
6. High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes.
Anderson JC; Willey CD; Mehta A; Welaya K; Chen D; Duarte CW; Ghatalia P; Arafat W; Madan A; Sudarshan S; Naik G; Grizzle WE; Choueiri TK; Sonpavde G
PLoS One; 2015; 10(9):e0139267. PubMed ID: 26406598
[TBL] [Abstract] [Full Text] [Related]
7. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study.
Gadd S; Beezhold P; Jennings L; George D; Leuer K; Huang CC; Huff V; Tognon C; Sorensen PH; Triche T; Coffin CM; Perlman EJ
J Pathol; 2012 Sep; 228(1):119-30. PubMed ID: 22374738
[TBL] [Abstract] [Full Text] [Related]
8. [Role of CD2-associated protein and nephrin expression in multilocular cystic renal cell carcinoma].
Gong K; Zhao ZX; Lü TJ; Jin J
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):543-7. PubMed ID: 19567077
[TBL] [Abstract] [Full Text] [Related]
9. [Molecular genetic mechanism of the kidney cancer].
Nakaigawa N; Yao M; Kishida T; Kubota Y
Nihon Rinsho; 2001 Jan; 59(1):104-9. PubMed ID: 11197838
[TBL] [Abstract] [Full Text] [Related]
10. Differential expression of SHP2, a protein-tyrosine phosphatase with src homology-2 domains, in various types of renal tumour.
Kuroda N; Hayashi Y; Matozaki T; Hanioka K; Gotoh A; Wang W; Uchida H; Hashimoto K; Iwai Y; Kawasaki K; Imai Y; Kasuga M; Itoh H
Virchows Arch; 1998 Oct; 433(4):331-9. PubMed ID: 9808435
[TBL] [Abstract] [Full Text] [Related]
